Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2017

View Archived Issues

FDA grants orphan drug status to ADC Therapeutics' ADCT-402

Dragonfly Therapeutics enters strategic collaboration with Celgene

Tarix Orphan's TXA-127 granted orphan drug status in E.U. for epidermolysis bullosa

Coherus BioSciences receives complete response letter from FDA for CHS-1701

Spero Therapeutics gives update on development of antibacterial agents

Gilead Sciences submits NDA in U.S. for bictegravir/emtricitabine/tenofovir alafenamide

FDA grants rare pediatric disease designation to Fibrocell Science's FCX-013

SLC6A6 gene variant linked to vision loss is possibly amenable to nutritional therapy

Numerate to identify clinical candidates for Takeda using AI-driven platform

Update on Pieris Pharmaceuticals' collaboration agreement with AstraZeneca

Seres initiates phase III study of SER-109 in recurrent C. difficile infection

New clinical outcomes trial of Jardiance planned in chronic kidney disease

Sunshine Lake Pharma discloses orexin OX1 and OX2 receptor antagonists

Phase II DART study of dalantercept plus axitinib in RCC misses primary endpoint

Medshine Discovery patents IL-6 release inhibitors

Roche discovers cathepsin S inhibitors

Alkermes begins phase IIIb study of ALKS-5461 for adjunctive treatment of major depressive disorder

FDA accepts Bioverativ's IND for BIVV-001 for hemophilia A

Genentech and Roche identify JAK inhibitors

Blueprint Medicines discloses neurotrophic tyrosine kinase receptors inhibitors

Aimmune updates progress of phase III PALISADE trial of AR-101 in peanut allergy

Rotary and Bill & Melinda Gates Foundation announce commitment to eradicate polio

Final overall survival data reported for phase III trial of cediranib in ovarian cancer

Final data for talazoparib in BRCA-mutated breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...